GR3021569T3 - Use of xanthine derivatives against peptic ulcers - Google Patents

Use of xanthine derivatives against peptic ulcers

Info

Publication number
GR3021569T3
GR3021569T3 GR960402903T GR960402903T GR3021569T3 GR 3021569 T3 GR3021569 T3 GR 3021569T3 GR 960402903 T GR960402903 T GR 960402903T GR 960402903 T GR960402903 T GR 960402903T GR 3021569 T3 GR3021569 T3 GR 3021569T3
Authority
GR
Greece
Prior art keywords
peptic ulcers
xanthine derivatives
derivatives against
alkyl
against peptic
Prior art date
Application number
GR960402903T
Other languages
English (en)
Inventor
Toshizo Tanaka
Shoryo Hayashi
Yuko Morioka
Ulrich Dr Gebert
Original Assignee
Hoechst Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Japan filed Critical Hoechst Japan
Publication of GR3021569T3 publication Critical patent/GR3021569T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
GR960402903T 1989-08-16 1996-11-07 Use of xanthine derivatives against peptic ulcers GR3021569T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP21018789 1989-08-16

Publications (1)

Publication Number Publication Date
GR3021569T3 true GR3021569T3 (en) 1997-02-28

Family

ID=16585226

Family Applications (1)

Application Number Title Priority Date Filing Date
GR960402903T GR3021569T3 (en) 1989-08-16 1996-11-07 Use of xanthine derivatives against peptic ulcers

Country Status (18)

Country Link
US (1) US5109003A (el)
EP (1) EP0413278B1 (el)
JP (1) JP2977242B2 (el)
KR (1) KR910004620A (el)
AT (1) ATE144900T1 (el)
AU (1) AU624987B2 (el)
CA (1) CA2023310A1 (el)
DD (1) DD298051A5 (el)
DE (1) DE69029069T2 (el)
DK (1) DK0413278T3 (el)
ES (1) ES2094132T3 (el)
GR (1) GR3021569T3 (el)
HU (1) HU207518B (el)
IE (1) IE902954A1 (el)
IL (1) IL95377A (el)
NZ (1) NZ234896A (el)
PT (1) PT95007A (el)
ZA (1) ZA906446B (el)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0570831A2 (de) * 1992-05-20 1993-11-24 Hoechst Aktiengesellschaft Verwendung von Xanthinderivaten zur Behandlung von Nervenschädigungen nach Unterbrechung der Blutzirkulation
US5354756A (en) * 1993-01-12 1994-10-11 Cell Therapeutics, Inc. Olefin-substituted long chain xanthine compounds
DE4411660A1 (de) * 1994-04-05 1995-10-12 Hoechst Ag Verwendung von Xanthinderivaten zur Reduktion der pathologischen Hyperreagibilität eosinophiler Granulozyten, neue Xanthinverbindungen und Verfahren zu deren Herstellung
US7122207B2 (en) * 1998-05-22 2006-10-17 Bristol-Myers Squibb Company High drug load acid labile pharmaceutical composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3525801A1 (de) * 1985-07-19 1987-01-22 Hoechst Ag Tertiaere hydroxyalkylxanthine, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung
JPS63225317A (ja) * 1986-10-06 1988-09-20 Hoechst Japan Kk 抗消化性潰瘍剤
IL100533A (en) * 1986-12-31 1994-05-30 Hoechst Roussel Pharma Pharmaceutical preparations containing a history of xanthine for VIH treatment and disease states
JP2661666B2 (ja) * 1988-02-19 1997-10-08 ヘキスト薬品工業株式会社 抗消化性潰瘍剤

Also Published As

Publication number Publication date
JPH03163019A (ja) 1991-07-15
JP2977242B2 (ja) 1999-11-15
HU905000D0 (en) 1991-01-28
EP0413278B1 (en) 1996-11-06
EP0413278A2 (en) 1991-02-20
AU624987B2 (en) 1992-06-25
HU207518B (en) 1993-04-28
ATE144900T1 (de) 1996-11-15
ZA906446B (en) 1991-05-29
KR910004620A (ko) 1991-03-29
IL95377A (en) 1994-08-26
EP0413278A3 (en) 1992-05-06
DE69029069D1 (de) 1996-12-12
HUT54688A (en) 1991-03-28
NZ234896A (en) 1993-10-26
CA2023310A1 (en) 1991-02-17
DE69029069T2 (de) 1997-04-10
IL95377A0 (en) 1991-06-30
DK0413278T3 (da) 1997-04-07
PT95007A (pt) 1991-04-18
AU6101890A (en) 1991-02-21
DD298051A5 (de) 1992-02-06
IE902954A1 (en) 1991-02-27
ES2094132T3 (es) 1997-01-16
US5109003A (en) 1992-04-28

Similar Documents

Publication Publication Date Title
IE860222L (en) Imidazole derivatives.
EP0288969A3 (en) Antiulcer composition
AU4200089A (en) Substituted beta-diketones
EP0413278A3 (en) Use of xanthine derivatives against peptic ulcers
IL89324A0 (en) Therapeutic agents for the treatment of peptic ulcer disease containing xanthine derivatives
EP0285284A3 (en) N-phenethylaminoalkyl-benzamide anti-arrhythmia agents
AU6063298A (en) Benzamide derivative, anti-ulcer drug, and antibacterial drug
MY110092A (en) Butyric acid derivatives
PT85866A (en) Process for the preparation of therapeutic agents for the treatment of peptic ulcers containing 1,2,3,6-tetrahydro-3-methyl-1-(5-oxohexyl)-7-propyl-purine,6-dione and their derivatives
NO974462D0 (no) Forbindelse til anvendelse ved fremstilling av alkylderivater av trazodon med CNS-aktivitet
HK34095A (en) Use of 2-oxo-imidazolidine derivatives in the treatment of kidney diseases